Lu Peng sold $610K of PHVS
Lu Peng (President) sold 15,000 shares of Pharvaris N.V. (PHVS) at $40.68 ($0.61M total) on 2026-09-08 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale provides fresh data on insider sentiment for PHVS, a micro‑cap biotech.
Market read
First‑hand insider sale information that may influence short‑term trading decisions for PHVS.
What to watch
Holding after sale remains 65,179 shares, indicating continued confidence despite the partial divestiture.
Background
SEC Form 4 filing discloses insider transactions for public companies.
Ticker impact
President Lu Peng sold 15,000 shares for $610,134 via a 10b5‑1 plan on Sep 8, 2026.
Potential modest downside pressure over the next few days.
The sale is sizable for a micro‑cap biotech and executed through a pre‑arranged plan, suggesting a neutral to slightly bearish impact.
Market effects
May raise concerns for other small‑cap biotech stocks if insider sales become frequent.
Limited to U.S. biotech investors; no broader regional effect.
Minimal global impact.
Counterpoint
The sale was pre‑arranged under a 10b5‑1 plan, which may not reflect current sentiment; the stock could be undervalued.
Key entities
- CompanyPharvaris N.V.
Biotech firm listed on NASDAQ under ticker PHVS.
- ExecutiveLu Peng
President of Pharvaris N.V. and reporting officer.
